CD274 and neoplasm: Future research endeavors can concentrate on devising strategies to counteract the immunosuppressive microenvironment, including the utilization of combinations of immune checkpoint inhibitors (like PD-1/PD-L1 antibodies) and vaccines in order to bolster anti-tumor immune responses.